Standardising RNA profiling based biomarker application in cancer—The need for robust control of technical variables by Stewart, J, Richman, S, Maughan, T, Lawler, M, Dunne, P, Salto-Tellez, M

Potential quality pitfalls of digitalized whole slide image of breast pathology in routine practice by Atallah, NM, Toss, MS, Verrill, C, Salto-Tellez, M, Snead, D, Rakha, EA

A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases by Ong, C, Maxwell, P, Alvi, M, McQuaid, S, Waugh, D, Mills, I, Salto-Tellez, M

Training and accreditation standards for pathologists undertaking clinical trial work by Rees, G, Salto-Tellez, M, Lee, J, Oien, K, Verrill, C, Freeman, A, Mirabile, I, West, N

Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspec... by Browning, L, Colling, R, Rakha, E, Rajpoot, N, Rittscher, J, James, JA, Salto-Tellez, M, Snead, DRJ, Verrill, C

KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer by Singh, VK, Makhlouf, Y, Sarker, MMK, Craig, S, Baena, J, Greene, C, Mason, L, James, JA, Salto-Tellez, M, O’Reilly, P, Maxwell, P

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study by McCain, RS, McManus, DT, McQuaid, S, James, JA, Salto-Tellez, M, Reid, NB, Craig, S, Chisambo, C, Bingham, V, McCarron, E, Parkes, E, Turkington, RC, Coleman, HG

Activation of STING-dependent innate immune signaling by S-phase-specific DNA damage in breast cancer by Parkes, EE, Walker, SM, Taggart, LE, McCabe, N, Knight, LA, Wilkinson, R, McCloskey, KD, Buckley, NE, Savage, KI, Salto-Tellez, M, McQuaid, S, Harte, MT, Mullan, PB, Harkin, DP, Kennedy, RD

Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability. by Savage, K, Gorski, J, Barros, E, Irwin, G, Manti, L, Powell, A, Pellagatti, A, Lukashchuk, N, McCance, D, McCluggage, W, Schettino, G, Salto-Tellez, M, Boultwood, J, Richard, D, McDade, S, Harkin, D

Automated tumour recognition and digital pathology scoring unravels new role for PD-L1 in predicting good outcome in ER-/HER2+ breast cancer by Humphries, MP, Hynes, S, Bingham, V, Cougot, D, James, J, Patel-Socha, F, Parkes, EE, Blayney, JK, O’Rorke, MA, Irwin, GW, McArt, DG, Kennedy, RD, Mullan, PB, McQuaid, S, Salto-Tellez, M, Buckley, NE

Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability by Savage, K, Gorski, J, Barros, E, Irwin, G, Manti, L, Powell, A, Pellagatti, A, Lukashchuk, N, McCance, D, McCluggage, W, McCluggage, W, Schettino, G, Schettino, G, Salto-Tellez, M, Boultwood, J, Richard, D, McDade, S, Harkin, D

MErCuRIC1: A phase 1a study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in patients with advanced solid tumours by Wilson, R, Middleton, M, Houlden, J, Van Schaeybroeck, S, Rolfo, C, Elez, E, Taieb, J, André, T, Bardelli, A, Laurent-Puig, P, Tabernero, J, Peeters, M, Maughan, T, Roberts, C, Love, S, Lawler, M, Salto-Tellez, M, Grayson, M, Popovici, V, Di Nicolantonio, F

In-depth clinical and biological exploration of DNA damage immune response as a biomarker for oxaliplatin use in colorectal cancer by Malla, SB, Fisher, DJ, Domingo, E, Blake, A, Hassanieh, S, Redmond, KL, Richman, SD, Youdell, M, Walker, SM, Logan, GE, Chatzipli, A, Amirkhah, R, Humphries, MP, Craig, SG, McDermott, U, Seymour, MT, Morton, DG, Quirke, P, West, NP, Salto-Tellez, M, Kennedy, RD, Johnston, PG, Tomlinson, I, Koelzer, VH, Campo, L, Kaplan, RS, Longley, DB, Lawler, M, Maughan, TS, Brown, LC, Dunne, PD

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma by Turkington, RC, Knight, LA, Blayney, JK, Secrier, M, Douglas, R, Parkes, EE, Sutton, EK, Stevenson, L, McManus, D, Halliday, S, McCavigan, AM, Logan, GE, Walker, SM, Steele, CJ, Perner, J, Bornschein, J, MacRae, S, Miremadi, A, McCarron, E, McQuaid, S, Arthur, K, James, JA, Eatock, MM, O'Neill, R, Noble, F, Underwood, TJ, Harkin, DP, Salto-Tellez, M, Fitzgerald, RC, Kennedy, RD, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group

Metastasis and immune evasion from extracellular cGAMP hydrolysis by Li, J, Duran, MA, Dhanota, N, Chatila, WK, Bettigole, SE, Kwon, J, Sriram, RK, Humphries, MP, Salto-Tellez, M, James, JA, Hanna, MG, Melms, JC, Vallabhaneni, S, Litchfield, K, Usaite, I, Biswas, D, Bareja, R, Li, HW, Martin, ML, Dorsaint, P, Cavallo, J-A, Li, P, Pauli, C, Gottesdiener, L, DiPardo, BJ, Hollmann, TJ, Merghoub, T, Wen, HY, Reis-Filho, JS, Riaz, N, Su, S-SM, Kalbasi, A, Vasan, N, Powell, SN, Wolchok, JD, Elemento, O, Swanton, C, Shoushtari, AN, Izar, B, Parkes, EE, Bakhoum, SF